Endoscopic management for patients with serrated polyposis syndrome is feasible and effective : A prospective observational study at a tertiary center.
Recruiting
- Conditions
- C18Malignant neoplasm of colon
- Registration Number
- DRKS00005031
- Lead Sponsor
- Dr. Horst-Schmidt-KlinikKlinik für Gastroenterologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
All patients who fullfilled the criteria (WHO) for serrated polyposis syndrom
Exclusion Criteria
Patients who had severe comorbidity (over grade III in the American Society of Anesthesiologists classification) or were receiving oral anticoagulation treatment were excluded
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of complete Remission after 3-6 months and rate of residual lesions, recurrences and intervall carcinomas during surveillance. The surveillance interval is at least 12 months.
- Secondary Outcome Measures
Name Time Method complications, rate of colorectal carcinomas at first resection and during surveillance ( At least one year) Evaluation of cancer rate in first degree relatives (questionnaire)